Clinical Trials Sponsored by Gruppo+Italiano+Trapianto+di+Midollo+Osseo

Total 18 results

Gruppo Italiano Trapianto di Midollo Osseo

Completed

Busulfan (BU) Plus Fludarabine Vs Intravenous BU Plus Cyclophosphamide as Conditioning Regimens Prior Allogeneic Hematopoetic Stem Cells Transplant (HSCT) in AML (GITMO-AMLR2)

Acute Myeloid Leukemia (AML)

Italy, Israel
Gruppo Italiano Trapianto di Midollo Osseo

Completed

Phase I/II for Safety and Efficacy of Nilotinib in a Population Steroid-refractory/or Steroid-dependent cGVHD (Nilo-cGVHD)

Chronic Graft Versus Host Disease

Israel, Italy
Gruppo Italiano Trapianto di Midollo Osseo

Completed

Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) With Newly Diagnosed AML Eligible for Allo-SCT

Acute Myeloid Leukemia

Italy
Gruppo Italiano Trapianto di Midollo Osseo

Completed

Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies (GITMO-PHYLOS)

Myeloid Malignancies

Italy
Gruppo Italiano Trapianto di Midollo Osseo

Completed

Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis (GITMO-MF2010)

Myelofibrosis

Italy
Gruppo Italiano Trapianto di Midollo Osseo

Recruiting

Pentaglobin in CRE and PA Neutropenic Infections (PENTALLO)

Septic Shock

Italy
Gruppo Italiano Trapianto di Midollo Osseo

Completed

Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant (GLOBAL)

Myelofibrosis | Chronic Myeloid Leukemia | Lymphoblastic Leukemia | Myelodysplasia | Acute Myeloblastic Leukemia | Lympho-proliferative Diseases

Italy
Gruppo Italiano Trapianto di Midollo Osseo

Completed

A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia (Gandalf-01)

Acute Leukemia

Italy
Gruppo Italiano Trapianto di Midollo Osseo

Completed

A Prospective Observational Study for Evaluating CGVHD (GITMO-GVCrOSy)

Chronic Graft-Versus-Host Disease

Italy
Gruppo Italiano Trapianto di Midollo Osseo

Completed

Survey of Severe Infections by Gram Negative Bacteria in Patients Submitted to Stem Cell Transplant (GITMO-SIGNB)

Gram-Negative Bacterial Infections | Complications of Organ Transplant Stem Cells

Italy
Gruppo Italiano Trapianto di Midollo Osseo
Azienda Policlinico Umberto I

Completed

DSAs in Patients Undergoing Allo-HSCT From Mismatched Donors (AIBT_DSAs)

Hematologic Diseases | Stem Cell Transplant Complications

Italy
Gruppo Italiano Trapianto di Midollo Osseo
Azienda Ospedaliero-Universitaria Careggi

Completed

Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma (NEW_ALL_MM)

Multiple Myeloma | Stem Cell Transplant

Italy
Gruppo Italiano Trapianto di Midollo Osseo
Azienda Policlinico Umberto I

Completed

Prospective Survey of CMV, Herpesviruses Infections and Diseases in Allo-HSCT (CYTOALLOSURVEY)

Hematologic Diseases | Stem Cell Transplant Complications | Cytomegalovirus Viremia | Herpesvirus Infection

Italy
CANDONI ANNA
Gruppo Italiano Trapianto di Midollo Osseo

Completed

SCT in Ph Positive Acute Lymphoblastic Leukemia

Philadelphia Positive Acute Lymphoblastic Leukemia | SCT

Italy
Gruppo Italiano Trapianto di Midollo Osseo
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Completed

ALLO-SCT in Elderly Patients With Hematological Disease

Hematologic Diseases | Stem Cell Transplant Complications

Italy
Ciceri Fabio
Associazione Italiana per la Ricerca sul Cancro; Gruppo Italiano Trapianto...

Recruiting

Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways (GITMO-RELAPSE)

Acute Myeloid Leukemia, in Relapse

Italy
Gruppo Italiano Trapianto di Midollo Osseo
University of Rome Tor Vergata; National Marrow Donor Program; Associazione Italiana...

Completed

High Resolution Donor Recipient HLA Matching Level in Unrelated HSCT (GITMO-HLA-HR)

Hematologic Diseases

Italy
Azienda Ospedaliera San Giovanni Battista
Hoffmann-La Roche; University of Turin, Italy; Gruppo Italiano Trapianto di Midollo... and other collaborators

Unknown

Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma

Follicular Lymphoma

Italy

Clinical Trials Sponsored by Gruppo+Italiano+Trapianto+di+Midollo+Osseo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations